Purpose

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Conditions

Eligibility

Eligible Ages
Between 18 Years and 75 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS) - Able to ambulate overground - Relapse free for at least 1 month - Age ≥18 and ≤ 75 years - Participants using dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening

Exclusion Criteria

  • Orthopedic injuries, fractures, surgeries or other conditions affecting locomotor function or weight bearing

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Observation Gait quality observation
  • Diagnostic Test: Camera Based Kinematic Analysis
    Observational Study using Camera Based, Marker Less Kinematic Analysis of gait quality of persons with Multiple Sclerosis
    Other names:
    • OpenCap

Recruiting Locations

Shirley Ryan AbilityLab
Chicago, Illinois 60611
Contact:
Weena Dee, DPT
312-238-7503
wdee@sralab.org

More Details

Status
Recruiting
Sponsor
Shirley Ryan AbilityLab

Study Contact

Weena Dee
312-328-7503
wdee@sralab.org

Detailed Description

In rehabilitation in general, in order to track patients' progress and provide next steps, there is a need for easily obtainable, understandable, and objective measures of ability. Currently, there is no measure that clinicians can utilize to determine walking quality. While Gait Deviation Index has been validated and can reliably be used in adults who experienced a Spinal Cord Injury, it has not yet been validated in people with MS. After the MS-specific GDI is developed from this study, therapists and clinicians will be able use it as a reliable progress measure. Which may lead to the delivery of more effective therapy for patients with MS. Here we plan to measure body position with camera based tracking during your gait cycle.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.